Oncolytics Biotech (ONCY) Leadership Strengthens As Pelareorep Advances
Oncolytics Biotech Inc. (NASDAQ:ONCY) shared a leadership update on January 7, 2026. With the appointment of Dr. Eileen O’Reilly of Memorial Sloan Kettering Cancer Center, Dr.
Oncolytics Biotech Inc (ONCY)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Marshall Wace LLP Paul Marshall And Ian Wace | 262,170 | $228,087 | -20% | 0% |
| 2. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% | |
| 3. | Scientech Research Le Duan | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.84 | 29,500 | $24,839.00 | 109,000 | 2026-02-12 | Filing | |
| $0.84 | 5,600 | $4,681.60 | 79,500 | 2026-02-11 | Filing | |
| $0.84 | 12,000 | $10,104.00 | 287,515 | 2026-02-12 | Filing | |
| $0.84 | 30,000 | $25,338.00 | 492,414 | 2026-02-12 | Filing | |
| $0.83 | 12,132 | $10,033.16 | 282,818 | 2026-02-12 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 426,518 | $372,777 | 0% | |
| 2. | 258,306 | $225,759 | 0.04% | |
| 3. | 208,150 | $181,923 | 0.01% | |
| 4. | 169,899 | $148,492 | 0% | |
| 5. | 69,842 | $72,258 | 0% |
News See All
10 Stocks Under $1 That Will Explode
U.S. equity markets are beginning their 2026 journey without taking a major break from existing trends, according to Morgan Stanley CIO and chief U.S.
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q1 2025 Earnings Call Transcript
Operator: Good afternoon, and welcome to Oncolytics Biotech First Quarter Conference Call. All participants are in a listen-only mode.
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q4 2024 Earnings Call Transcript
Operator: Good morning, and welcome to Oncolytics Biotech Inc.'s fourth quarter and full year 2024 conference call. All participants are in a listen-only mode.
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q3 2024 Earnings Call Transcript
Operator: Good afternoon and welcome to Oncolytics Biotech's Third Quarter 2024 Conference Call. All participants are in a listen-only mode.
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q2 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome to Oncolytics Biotech Second Quarter 2024 Conference Call. All participants are now in a listen-only mode.
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q1 2024 Earnings Call Transcript
Operator: Good afternoon and welcome to Oncolytics Biotech's First Quarter 2024 Conference Call. [Operator Instructions]. Please be advised that this call is being recorded at the company's request.
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q4 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to Oncolytics Biotech's Fourth Quarter and Full Year 2023 Conference Call. All participants are now in a listen-only mode.
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q3 2023 Earnings Call Transcript
Operator: Good morning, and welcome to Oncolytics Biotech's Third Quarter 2023 Conference Call. All participants are now in listen-only mode.
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q2 2023 Earnings Call Transcript
Operator: Good morning, and welcome to Oncolytics Biotech's Second Quarter 2023 Conference Call. All participants are now in listen-only mode.
Hedge Fund Resource Center Billionaire Hedge Funds
